These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29439640)

  • 1. An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform.
    Katayama H; Matsumoto T; Wada H; Fujimoto N; Toyoda J; Abe Y; Ohishi K; Yamashita Y; Ikejiri M; Habe K; Katayama N
    Clin Appl Thromb Hemost; 2018 Oct; 24(7):1170-1176. PubMed ID: 29439640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comments to: An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing Hemophilia or Inhibitor.
    Matsumoto T; Wada H; Ohishi K; Yamashita Y; Ikejiri M; Katayama N
    Clin Appl Thromb Hemost; 2019; 25():1076029618824419. PubMed ID: 30808219
    [No Abstract]   [Full Text] [Related]  

  • 3. An Evaluation of the Activated Partial Thromboplastin Time Waveform.
    Matsumoto T; Wada H; Fujimoto N; Toyoda J; Abe Y; Ohishi K; Yamashita Y; Ikejiri M; Hasegawa K; Suzuki K; Imai H; Nakatani K; Katayama N
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):764-770. PubMed ID: 28884611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activated partial thromboplastin time-clot waveform analysis in hemophilia: Does it help in differentiation?
    Mannan KA; Kumar N; Ahluwalia J; Hans C; Kler A; Prakash G; Jain R
    Int J Lab Hematol; 2023 Apr; 45(2):241-249. PubMed ID: 36495061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of hemostatic abnormalities in major orthopedic surgery patients treated with edoxaban by APTT waveform.
    Hasegawa M; Wada H; Tone S; Yamaguchi T; Wakabayashi H; Ikejiri M; Watanabe M; Fujimoto N; Matsumoto T; Ohishi K; Yamashita Y; Katayama N; Sudo A
    Int J Lab Hematol; 2018 Feb; 40(1):49-55. PubMed ID: 28869359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test.
    Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Aoki T
    Thromb Res; 2014 Aug; 134(2):503-9. PubMed ID: 24935674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New quantitative aPTT waveform analysis and its application in laboratory management of haemophilia A patients.
    Milos M; Coen Herak D; Zupancic-Salek S; Zadro R
    Haemophilia; 2014 Nov; 20(6):898-904. PubMed ID: 25273337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C).
    Shima M; Matsumoto T; Fukuda K; Kubota Y; Tanaka I; Nishiya K; Giles AR; Yoshioka A
    Thromb Haemost; 2002 Mar; 87(3):436-41. PubMed ID: 11916076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive comparison of global coagulation assays to differentiate lupus anticoagulant from acquired hemophilia A in patients with prolonged APTT.
    Chikasawa Y; Amano K; Shinozawa K; Bingo M; Miyashita R; Yamaguchi T; Mitsuhashi A; Inaba H; Hagiwara T; Kinai E
    Int J Hematol; 2023 Nov; 118(5):577-588. PubMed ID: 37751038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clot waveform analysis for perioperative hemostatic monitoring in a hemophilia A patient on emicizumab undergoing liver transplantation.
    Awane M; Wakui M; Ozaki Y; Kondo Y; Oka S; Fujimori Y; Yatabe Y; Arai T; Yamada Y; Hori S; Obara H; Hasegawa Y; Matsushita H
    Clin Chim Acta; 2023 Apr; 544():117339. PubMed ID: 37076096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of activated partial thromboplastin time clot waveform analysis and thrombin generation test in the evaluation of bleeding phenotype in Hemophilia A.
    Dave RG; Geevar T; Mammen JJ; Vijayan R; Mahasampath G; Nair SC
    Indian J Pathol Microbiol; 2021; 64(1):117-122. PubMed ID: 33433420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Assessment of Factor VIII Activity by Template Matching Utilizing Weighted Average Parameters from Comprehensive Clot Waveform Analysis.
    Shimonishi N; Ogiwara K; Oda Y; Kawabe T; Okazaki S; Shima M; Nogami K
    Thromb Haemost; 2021 Feb; 121(2):164-173. PubMed ID: 32828071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hemostatic abnormalities in patients who underwent major hepatobiliary pancreatic surgery using activated partial thromboplastin time-clot waveform analysis.
    Maeda K; Wada H; Shinkai T; Tanemura A; Matsumoto T; Mizuno S
    Thromb Res; 2021 May; 201():154-160. PubMed ID: 33862519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity.
    Matsumoto T; Nogami K; Shima M
    Int J Hematol; 2017 Feb; 105(2):174-183. PubMed ID: 27730530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT.
    Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
    Int J Lab Hematol; 2019 Feb; 41(1):60-68. PubMed ID: 30248243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The First-Derivative Curve of the Coagulation Waveform Reveals the Cause of aPTT Prolongation.
    Shimomura D; Matsumoto T; Sugimoto K; Takata T; Kouno A; Shimada M; Matsuo S; Kamioka M
    Clin Appl Thromb Hemost; 2020; 26():1076029620978810. PubMed ID: 33372824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic analysis of lupus anticoagulant using clot waveform analysis in activated partial thromboplastin time prolonged cases: A retrospective analysis.
    Kanouchi K; Narimatsu H; Shirata T; Morikane K
    Health Sci Rep; 2021 Jun; 4(2):e258. PubMed ID: 33738342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clot waveform analysis using CS-2000i™ distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A.
    Matsumoto T; Nogami K; Tabuchi Y; Yada K; Ogiwara K; Kurono H; Arai N; Shima M
    Haemophilia; 2017 Sep; 23(5):e427-e435. PubMed ID: 28750470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged Activated Partial Thromboplastin Time: Difficulties in Discriminating Coexistent Factor VIII Inhibitor and Lupus Anticoagulant.
    Ames PR; Graf M; Archer J; Scarpato N; Iannaccone L
    Clin Appl Thromb Hemost; 2015 Mar; 21(2):149-54. PubMed ID: 24989713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall hemostasis potential and aPTT-clot waveform analysis as powerful laboratory diagnostic tools for identification of hemophilia A patients with unexpected bleeding phenotype.
    Milos M; Coen Herak D; Mahmoud Hourani Soutari N; Pavic J; Zupancic-Salek S; Zadro R; Antovic JP
    Int J Lab Hematol; 2021 Apr; 43(2):273-280. PubMed ID: 32964648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.